X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs UNICHEM LAB - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON UNICHEM LAB BIOCON /
UNICHEM LAB
 
P/E (TTM) x 40.6 285.1 14.2% View Chart
P/BV x 7.0 0.7 1,076.3% View Chart
Dividend Yield % 0.2 2.6 6.4%  

Financials

 BIOCON    UNICHEM LAB
EQUITY SHARE DATA
    BIOCON
Mar-18
UNICHEM LAB
Mar-18
BIOCON /
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,188382 311.0%   
Low Rs305234 130.3%   
Sales per share (Unadj.) Rs68.7116.3 59.1%  
Earnings per share (Unadj.) Rs7.6-18.9 -39.9%  
Cash flow per share (Unadj.) Rs14.0-11.7 -119.0%  
Dividends per share (Unadj.) Rs1.005.00 20.0%  
Dividend yield (eoy) %0.11.6 8.3%  
Book value per share (Unadj.) Rs86.3381.0 22.7%  
Shares outstanding (eoy) m600.0070.34 853.0%   
Bonus/Rights/Conversions ISBB-  
Price / Sales ratio x10.92.6 410.1%   
Avg P/E ratio x98.9-16.3 -607.2%  
P/CF ratio (eoy) x53.4-26.2 -203.7%  
Price / Book Value ratio x8.60.8 1,069.3%  
Dividend payout %13.2-26.4 -50.1%   
Avg Mkt Cap Rs m447,90021,668 2,067.1%   
No. of employees `0006.12.3 269.7%   
Total wages/salary Rs m9,3112,006 464.1%   
Avg. sales/employee Rs Th6,705.83,587.8 186.9%   
Avg. wages/employee Rs Th1,514.2880.0 172.1%   
Avg. net profit/employee Rs Th736.9-583.7 -126.2%   
INCOME DATA
Net Sales Rs m41,2348,180 504.1%  
Other income Rs m2,062610 338.0%   
Total revenues Rs m43,2968,790 492.5%   
Gross profit Rs m8,291-1,320 -628.0%  
Depreciation Rs m3,851505 762.4%   
Interest Rs m61580 767.8%   
Profit before tax Rs m5,887-1,295 -454.5%   
Minority Interest Rs m2130-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,56933 4,694.8%   
Profit after tax Rs m4,531-1,331 -340.4%  
Gross profit margin %20.1-16.1 -124.6%  
Effective tax rate %26.7-2.6 -1,033.0%   
Net profit margin %11.0-16.3 -67.5%  
BALANCE SHEET DATA
Current assets Rs m41,48623,318 177.9%   
Current liabilities Rs m21,4134,635 462.0%   
Net working cap to sales %48.7228.4 21.3%  
Current ratio x1.95.0 38.5%  
Inventory Days Days64122 52.5%  
Debtors Days Days94121 77.5%  
Net fixed assets Rs m50,6618,163 620.6%   
Share capital Rs m3,000141 2,132.2%   
"Free" reserves Rs m48,80826,660 183.1%   
Net worth Rs m51,80826,801 193.3%   
Long term debt Rs m17,8983 542,363.6%   
Total assets Rs m99,89731,890 313.3%  
Interest coverage x10.6-15.2 -69.7%   
Debt to equity ratio x0.30 280,570.2%  
Sales to assets ratio x0.40.3 160.9%   
Return on assets %5.2-3.9 -131.3%  
Return on equity %8.7-5.0 -176.1%  
Return on capital %9.6-4.5 -212.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,0584,356 276.8%   
Fx outflow Rs m7,3480-   
Net fx Rs m4,7104,356 108.1%   
CASH FLOW
From Operations Rs m6,621-1,123 -589.4%  
From Investments Rs m-6,84016,487 -41.5%  
From Financial Activity Rs m-2,397-8,811 27.2%  
Net Cashflow Rs m-2,6126,552 -39.9%  

Share Holding

Indian Promoters % 40.4 50.1 80.6%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 15.1 55.6%  
FIIs % 10.7 3.0 356.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 31.7 62.8%  
Shareholders   109,995 20,176 545.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   PLETHICO PHARMA  DIVIS LABORATORIES  FULFORD INDIA  ALKEM LABORATORIES  AJANTA PHARMA  

Compare BIOCON With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Downtrend; Sensex Ends 495 Points Lower(Closing)

Indian share markets witnessed most of the selling pressure during closing hours and ended their trading session on a negative note.

Related Views on News

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Apr 22, 2019 03:33 PM

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS